See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Memorial Day
Cannes Film Festival
Artificial Intelligence
Harvard
Regulation
Social Media
Donald Trump
Education
Work
Natural Disasters
Cryptocurrency
European Union
Published • loading... • Updated

First patient dosed in Phase 2 trial testing mirivadelgat for PH-ILD

Summary by Pulmonary Hypertension News
The first participant has been dosed in Foresee's Phase 2 trial testing the experimental oral therapy mirivadelgat in people with PH-ILD.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Pulmonary Hypertension NewsPulmonary Hypertension News

First patient dosed in Phase 2 trial testing mirivadelgat for PH-ILD

The first participant has been dosed in Foresee's Phase 2 trial testing the experimental oral therapy mirivadelgat in people with PH-ILD.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pulmonary Hypertension News broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Maryland

Maryland

News
For You
SearchBlindspotLocal